Cornel J H, Bax J J, Elhendy A, Maat A P, Kimman G J, Geleijnse M L, Rambaldi R, Boersma E, Fioretti P M
Department of Cardiology, Medical Center Alkmaar, The Netherlands.
J Am Coll Cardiol. 1998 Apr;31(5):1002-10. doi: 10.1016/s0735-1097(98)00067-9.
This study sought to evaluate the time course of improvement of left ventricular (LV) dysfunction in stable patients and its implications on the accuracy of dobutamine echocardiography for predicting improvement after surgical revascularization.
Little is known about the optimal timing for evaluation of postrevascularization recovery of the contractile function of viable myocardium.
Sixty-one patients with chronic ischemic LV dysfunction scheduled for elective surgical revascularization were prospectively selected. They underwent dobutamine echocardiography (5 to 40 microg/kg body weight per min) and radionuclide ventriculography both preoperatively and at 3-month follow-up. At 14 months, another evaluation of LV function was obtained. To analyze echocardiograms, a 16-segment model and a five-point scoring system were used. Dyssynergic segments were considered likely to recover in the presence of a biphasic contractile response to dobutamine. Improvement of global function was defined as a > or =5% increase in LV ejection fraction (LVEF).
Of the 61 patients, LVEF improved in 12 at 3 months and in 19 at late follow-up (from 32+/-8% to 42+/-9%, p < 0.0001). The frequency and time course of improvement of LVEF were similar in patients with mild and severe LV dysfunction. A biphasic response, identified in 186 of the 537 dyssynergic segments, was predictive of recovery in 63% at 3 months and in 75% at late follow-up. The positive predictive value was best in the most severe dyssynergic segments (90% vs. 67%). Other responses were highly predictive for nonrecovery (92%). The sensitivity and specificity for improvement of global function on a patient basis (> or =4 biphasic segments) were 89% and 81%, respectively, at late follow-up.
Serial postoperative follow-up studies demonstrate incomplete recovery of contractile function at 3 months. The diagnostic accuracy of dobutamine echocardiography for predicting recovery is dependent on three factors: the combining of low and high dobutamine dosages, the severity of regional dyssynergy and the timing of evaluation.
本研究旨在评估稳定型患者左心室(LV)功能障碍改善的时间进程及其对多巴酚丁胺超声心动图预测外科血运重建术后改善情况准确性的影响。
关于评估存活心肌收缩功能血运重建术后恢复的最佳时机知之甚少。
前瞻性选取61例计划择期进行外科血运重建的慢性缺血性左心室功能障碍患者。他们在术前及3个月随访时均接受了多巴酚丁胺超声心动图检查(5至40微克/千克体重每分钟)和放射性核素心室造影。在14个月时,再次评估左心室功能。分析超声心动图时,采用16节段模型和五点评分系统。在对多巴酚丁胺出现双相收缩反应时,不协调节段被认为可能恢复。整体功能的改善定义为左心室射血分数(LVEF)增加≥5%。
61例患者中,12例在3个月时LVEF改善,19例在后期随访时改善(从32±8%增至42±9%,p<0.0001)。轻度和重度左心室功能障碍患者LVEF改善的频率和时间进程相似。在537个不协调节段中的186个节段发现双相反应,其预测3个月时恢复的准确率为63%,后期随访时为75%。阳性预测值在最严重的不协调节段中最佳(90%对67%)。其他反应对未恢复具有高度预测性(92%)。在后期随访时,基于患者整体功能改善(≥4个双相节段)的敏感性和特异性分别为89%和81%。
术后系列随访研究表明,3个月时收缩功能未完全恢复。多巴酚丁胺超声心动图预测恢复的诊断准确性取决于三个因素:低剂量和高剂量多巴酚丁胺联合使用、局部不协调的严重程度以及评估时间。